Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Salive

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
American Journal of Public Health|December 1, 1993
Predictors of nursing home admission in a biracial populationM E Salive, K S Collins, D J Foley, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2001
Proactive safety surveillanceE A Bortnichak, R P Wise, M E Salive, et al.
JAMA|October 5, 1994
Serum albumin level and physical disability as predictors of mortality in older personsM C Corti, J M Guralnik, M E Salive, et al.
The New England Journal of Medicine|March 2, 1995
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disabilityJ M Guralnik, L Ferrucci, E M Simonsick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 1, 1996
Progressive versus catastrophic disability: a longitudinal view of the disablement processL Ferrucci, J M Guralnik, E Simonsick, et al.
Public Health Reports (Washington, D.C. : 1974)|July 1, 1993
Risk factors for septicemia-associated mortality in older adultsM E Salive, R B Wallace, A M Ostfeld, et al.
Sexually Transmitted Diseases|October 1, 1989
Gonorrhea prevalence in the Maryland state prisonsE F Ellerbeck, D Vlahov, J P Libonati, et al.
Public Health Reports (Washington, D.C. : 1974)|May 1, 1993
Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adultsM E Salive, S Satterfield, A M Ostfeld, et al.
Ophthalmology|December 1, 1992
Functional blindness and visual impairment in older adults from three communitiesM E Salive, J Guralnik, W Christen, et al.
Pediatrics|October 4, 2000
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)M M Braun, G T Mootrey, M E Salive, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
American Journal of Public Health|December 1, 1993
Predictors of nursing home admission in a biracial populationM E Salive, K S Collins, D J Foley, et al.
Pharmacoepidemiology and Drug Safety|August 15, 2001
Proactive safety surveillanceE A Bortnichak, R P Wise, M E Salive, et al.
JAMA|October 5, 1994
Serum albumin level and physical disability as predictors of mortality in older personsM C Corti, J M Guralnik, M E Salive, et al.
The New England Journal of Medicine|March 2, 1995
Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disabilityJ M Guralnik, L Ferrucci, E M Simonsick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 1, 1996
Progressive versus catastrophic disability: a longitudinal view of the disablement processL Ferrucci, J M Guralnik, E Simonsick, et al.
Public Health Reports (Washington, D.C. : 1974)|July 1, 1993
Risk factors for septicemia-associated mortality in older adultsM E Salive, R B Wallace, A M Ostfeld, et al.
Sexually Transmitted Diseases|October 1, 1989
Gonorrhea prevalence in the Maryland state prisonsE F Ellerbeck, D Vlahov, J P Libonati, et al.
Public Health Reports (Washington, D.C. : 1974)|May 1, 1993
Disability and cognitive impairment are risk factors for pneumonia-related mortality in older adultsM E Salive, S Satterfield, A M Ostfeld, et al.
Ophthalmology|December 1, 1992
Functional blindness and visual impairment in older adults from three communitiesM E Salive, J Guralnik, W Christen, et al.
Pediatrics|October 4, 2000
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)M M Braun, G T Mootrey, M E Salive, et al.
Pageof 7